Suppr超能文献

人参皂苷 Rg1 防治高原缺氧性急性肺损伤。

Ginsenoside Rg1 Prevents and Treats Acute Pulmonary Injury Induced by High-Altitude Hypoxia.

机构信息

School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.

出版信息

Int J Mol Sci. 2024 Nov 9;25(22):12051. doi: 10.3390/ijms252212051.

Abstract

This study aimed to investigate the protective effects of ginsenoside Rg1 on high-altitude hypoxia-induced acute lung injury (ALI) and elucidated its molecular targets and related pathways, specifically its association with the fluid shear stress pathway. Using a combination of bioinformatics analysis and both in vivo and in vitro experiments, we assessed the role of ginsenoside Rg1 in mitigating physiological and biochemical disturbances induced by hypoxia. In the in vivo experiments, we measured arterial blood gas parameters, levels of inflammatory cells and cytokines, erythrocyte and platelet parameters, and conducted histological analysis in rats. The in vitro experiments utilized human pulmonary microvascular endothelial cells (HPMECs) and A549 cells to examine cell viability, intracellular reactive oxygen species (ROS) and Ca⁺ levels, and mitochondrial function. The results of the in vivo experiments demonstrate that ginsenoside Rg1 significantly increased arterial blood oxygen partial pressure and saturation, elevated arterial blood glucose levels, and stabilized respiratory and metabolic functions in rats. It also reduced inflammatory cells and cytokines, such as tumor necrosis factor-α and interleukin-6, and improved erythrocyte and platelet abnormalities, supporting its protective role through the regulation of the fluid shear stress pathway. Histological and ultrastructural analyses revealed that Rg1 significantly protected lung tissue structure and organelles. In vitro experiments further confirmed that Rg1 improved cell viability in HPMEC and A549 cells under hypoxic conditions, decreased intracellular ROS and Ca⁺ levels, and enhanced mitochondrial function. These findings collectively demonstrate that ginsenoside Rg1 exerts significant protective effects against high-altitude hypoxia-induced ALI by enhancing oxygen delivery and utilization, reducing inflammatory responses, and maintaining cellular metabolism and vascular function. Notably, the protective effects of Rg1 are closely associated with the regulation of the fluid shear stress pathway, suggesting its potential for treating high-altitude hypoxia-related diseases.

摘要

本研究旨在探讨人参皂苷 Rg1 对高原缺氧性急性肺损伤(ALI)的保护作用,并阐明其分子靶点和相关通路,特别是其与流体切应力通路的关系。我们采用生物信息学分析以及体内和体外实验相结合的方法,评估了人参皂苷 Rg1 减轻缺氧引起的生理和生化紊乱的作用。在体内实验中,我们测量了大鼠的动脉血气参数、炎症细胞和细胞因子水平、红细胞和血小板参数,并进行了组织学分析。体外实验利用人肺微血管内皮细胞(HPMEC)和 A549 细胞检测细胞活力、细胞内活性氧(ROS)和 Ca⁺水平以及线粒体功能。体内实验结果表明,人参皂苷 Rg1 可显著增加大鼠动脉血氧分压和饱和度,提高动脉血糖水平,稳定呼吸和代谢功能。它还降低了炎症细胞和细胞因子,如肿瘤坏死因子-α和白细胞介素-6,并改善了红细胞和血小板异常,通过调节流体切应力通路发挥其保护作用。组织学和超微结构分析表明,Rg1 显著保护了肺组织结构和细胞器。体外实验进一步证实,Rg1 可改善 HPMEC 和 A549 细胞在缺氧条件下的细胞活力,降低细胞内 ROS 和 Ca⁺水平,增强线粒体功能。这些发现共同表明,人参皂苷 Rg1 通过增强氧的输送和利用、减少炎症反应以及维持细胞代谢和血管功能,对高原缺氧性 ALI 具有显著的保护作用。值得注意的是,Rg1 的保护作用与流体切应力通路的调节密切相关,提示其在治疗高原缺氧相关疾病方面具有潜在的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/88df/11593513/54f7d5fc08ea/ijms-25-12051-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验